CORRELATION OF AGE WITH HER2 NEU POSITIVITY
Study of prevalence of prognostic and predictive immunohistochemical markers er, PR and Her2/neu and their correlation with age in cases of female carcinoma breast in Bihar (Northern India)
5
Role of HER2 / neu expression in colorectal carcinomas and its correlation with histological grades
143
To Assess the Stromal Expression of CD10 in Invasive Ductal Carcinoma of Breast and It’s Correlation with Histological Grade, ER, PR AND HER2/neu Expression
129
Expression of Hormone Receptor and Human Epidermal Growth Factor Receptor (HER2/neu) Status of Breast Carcinoma and Their Correlation with Clinico-Pathological Parameters
7
Clinicopathological study of benign and malignant ovarian tumours and the role of HER2/neu and ER expression in these tumours
5
Evaluation of HER2/neu Expression in Carcinoma Cervix
160
Analysis in Carcinoma Stomach Her-2/neu Positivity by Immuno-histochemistry
122
Prognostic Implications of ER, PR and HER2/Neu Protein Expression in a Cohort of Breast Carcinoma
6
Original Article Immunohistochemistry study for HER2/neu expression in pre-neoplastic and neoplastic lesions of uterine cervix
9
Correlation of ER, PR and Her-2/Neu with Histological Variants of Breast Carcinoma.
69
HER 2 neu Expression in Colorectal Adenocarcinoma and Its Correlation with Clinicopathologic Variables
140
Evaluation of ER, PR, HER2 / neu Receptor Status in Breast Cancer - A Cross Sectional Study from Manipur
6
Update on HER 2 as a target for cancer therapy: HER2/neu peptides as tumour vaccines for T cell recognition
5
HER2/neu immunohistochemical expression in gastric carcinoma
8
Hunk is required for HER2/neu induced mammary tumorigenesis
15
HER2/neu-directed therapy for biliary tract cancer
9
Interpretation Guide for VENTANA anti-her2/neu (4B5)
16
Systematic assessment of HER2/neu in gynecologic neoplasms, an institutional experience
9
Expression of anaplastic lymphokinase and HER2/neu immunostaining in patients with breast carcinoma
6
Influence of Neoadjuvant Chemotherapy on HER2/neu Status in Invasive Breast Cancer
8